Number of participants with adverse events as a measure of safety and tolerability [ Time Frame: every 3 months up to 6 months ] [ Designated as safety issue: Yes ]Adverse events, including infections, transient increases in serum creatinine, gastrointestinal complaints, liver function disorder and glucose intolerance, etc.